Comprehensive assessment of circulating immune cell populations in response to stereotactic body radiation therapy in patients with liver cancer
Michael P. Gustafson(Mayo Clinic), Christopher L. Hallemeier(Mayo Clinic in Arizona), Lewis R. Roberts(Mayo Clinic), Sean S. Park(Mayo Clinic), Allan B. Dietz(Mayo Clinic), Svetlana Bornschlegl(Mayo Clinic), Dennis A. Gastineau(Mayo Clinic)
Cited by 34
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
The role of hepatic resection in the treatment of hepatocellular cancer
|Hepatology|2015|415